The Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam recently unveiled its World Trade Center (WTC) Tower, marking a significant stride towards establishing India as a prominent MedTech Hub India. This new facility aims to significantly boost medical technology entrepreneurship by providing a robust ecosystem for innovation. The tower adds one lakh square feet of advanced infrastructure, specifically designed to support the entire lifecycle of medical technology solutions from ideation to scaling.
Developing India’s MedTech Ecosystem
Indeed, the WTC Tower combines scientific laboratories, co-working spaces, and testing centers, thus offering startups vital resources. These amenities allow entrepreneurs to innovate, prototype, and effectively scale their medical solutions. AIC-AMTZ MediValley Incubation anchors the new tower, which is a pivotal entity in this initiative. MediValley, recognized as a dedicated health technology incubator within AMTZ, consistently supports innovators through various stages. It currently incubates 150 startups, with plans to expand to 300 by FY 2026. This expansion truly highlights a commitment to growth.
Funding and Global Exposure for MedTech Hub India
The incubation program provides crucial access to funding sources like DBT-BIRAC, NITI Aayog, DPIIT, ICMR, and the Department of Pharmaceuticals. Importantly, it also enables global exposure for Indian MedTech startups through partnerships with organizations such as the World Health Organization (WHO), the World Health Innovation Forum, TiE, and IASP. This broad network helps Indian innovators connect with international markets and expertise, fostering a truly global outlook for MedTech products originating from India. Moreover, such collaborations are essential for accelerating progress.
Regulatory Support and Advanced Facilities
Furthermore, MediValley’s location within the 270-acre AMTZ campus grants unparalleled access to essential regulatory and testing infrastructures. These include NABL-accredited labs, facilities for BIS recognition, CDSCO registration assistance, and ISO/IEC 17025 certification for testing and calibration. Compliance with CDSCO regulations is mandatory for medical devices in India, ensuring product safety, quality, and performance. India’s government actively promotes the MedTech sector through policies like the National Medical Device Policy and Production-Linked Incentive (PLI) schemes. The facility has mobilized over INR 60 crore in grants, including a recent INR 7 crore sanction from the Department of Pharmaceuticals. Such financial backing provides substantial support.
Pioneering the Next Generation of MedTech Leaders
Dr. Jitendra Sharma, Executive Chairman of AIC-AMTZ MediValley and Managing Director & Founder CEO of AMTZ, emphasizes the initiative’s core mission: “building capacity for India’s next generation of MedTech leaders.” He also highlighted that the upcoming 50,000 sq. ft. incubation hub will significantly strengthen India’s position as a global MedTech hub. This strategic expansion aligns with India’s broader vision of reducing import dependence and becoming a major global hub for medical equipment manufacturing, aiming for a market value of $50 billion by 2030. Consequently, this initiative fosters self-reliance and global competitiveness.
Frequently Asked Questions
Q1: What is the primary purpose of the WTC Tower at AMTZ?
A: The WTC Tower at AMTZ aims to boost MedTech entrepreneurship in India by providing advanced infrastructure, including scientific laboratories, co-working spaces, and testing centers, to support startups in innovating, prototyping, and scaling medical technology solutions.
Q2: How does the WTC Tower facilitate global engagement for MedTech startups?
A: The incubation program at the WTC Tower offers global exposure through strategic partnerships with international bodies like the World Health Organization (WHO), the World Health Innovation Forum, TiE, and IASP, helping Indian MedTech innovators connect worldwide.
Q3: What regulatory support is available at the AMTZ campus?
A: Startups at the AMTZ campus benefit from access to NABL-accredited labs, assistance with BIS recognition, CDSCO registration, and ISO/IEC 17025 certification for testing and calibration, ensuring compliance with Indian medical device regulations.
References
- WTC Tower Operationalized at AMTZ to Boost MedTech Entrepreneurship – ETHealthworld
- Healthcare Innovation in India | Bain & Company
- India emerging as MedTech hub; seeks collaboration for resilient medical device ecosystem – ETHealthWorld
- Why India is poised to become a global hub for MedTech manufacturing – Invest India
- India’s path to becoming a global hub of Med-Tech – Times of India
- Over 70% innovation in Indian MedTech startups driven by digital integration; several factors propel industry growth: EY Parthenon report
- WTC Visakhapatnam opens its Interim Office – World Trade Centers Association
- AIC – AMTZ Medivalley Incubation Council
- CDSCO Certification for India? – Clinipace
- Importance of CDSCO Certification for Medical Devices in India – LegalRaasta
- CDSCO Medical Device Registration Process (2025): Steps for Manufacturers & Importers
- AMTZ Inaugurates PYRAMED Building With A New 3D Printing Center Of Excellence On World Health Day | Manufactur3D
- Startup space at AMTZ expands to 1 lakh square feet – Pharmabiz.com
- World Trade Centre AMTZ – Official Website
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.